Related Experiment Video

Updated: Aug 8, 2026

Real-Time, Semi-Automated Fluorescent Measurement of the Airway Surface Liquid pH of Primary Human Airway Epithelial Cells
10:18

Real-Time, Semi-Automated Fluorescent Measurement of the Airway Surface Liquid pH of Primary Human Airway Epithelial Cells

Published on: June 13, 2019

7.7K

HRI London 2019: 10 Years of Excellence in Homeopathy Research

E Rachel Roberts1, Angelina J Mosley1, Alexander L Tournier1

  • 1Homeopathy Research Institute, London, United Kingdom.

Homeopathy : the Journal of the Faculty of Homeopathy
|February 6, 2020
PubMed

Insights

The Homeopathy Research Institute (HRI) convened its 4th International Research Conference in London, showcasing cutting-edge homeopathy research. The event highlighted advancements in homeopathic medicine and its scientific exploration.

Area of Science:

  • Homeopathy
  • Integrative Medicine
  • Evidence-Based Complementary Therapies

Background:

  • The Homeopathy Research Institute (HRI) hosted its 4th International Research Conference in London.
  • The conference marked HRI's 10th anniversary, celebrating a decade of advancing homeopathic research.
  • This event was HRI's largest and most international conference to date, with 352 attendees from 38 countries.

Purpose of the Study:

  • To summarize the scientific program presented at the HRI London 2019 conference.
  • To provide an overview of the latest research findings in homeopathy.
  • To document the proceedings of a major international homeopathy research event.

Main Methods:

  • A 2.5-day intensive scientific program was presented.
  • Presentations covered a range of topics within homeopathic research.
  • The conference facilitated scientific exchange among international researchers.

Main Results:

  • The conference featured a high-quality scientific program.
  • A vibrant and positive atmosphere characterized the event.
  • The event successfully brought together a diverse group of international participants.

Conclusions:

  • The HRI London 2019 conference was a significant event for the homeopathy research community.
  • The conference successfully celebrated HRI's 10th anniversary.
  • The event underscored the growing international interest and participation in homeopathic research.

More Related Videos

Bulk Droplet Vitrification for Primary Hepatocyte Preservation11:07

Bulk Droplet Vitrification for Primary Hepatocyte Preservation

Published on: October 25, 2019

5.9K
CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications08:32

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications

Published on: August 9, 2022

4.2K

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
High-Resolution Mass Spectrometry (HRMS)01:15

High-Resolution Mass Spectrometry (HRMS)

The resolution of a mass spectrometer depends on the efficiency of separating ions with different ion masses. The mass of an atom is approximated to the sum of the masses of protons and neutrons inside, considering the masses of protons and neutrons as equal. However, the masses of the proton (1.6726 × 10−24 g) and neutron (1.6749 × 10−24 g) are not truly equal. There is a minor error in the expression of atomic masses relative to the simplest atom of hydrogen. For example, the mass of helium...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However, frequent irregular...
Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...